bAntigen-presenting cells (APCs) are key players in the induction and regulation of immune responses. In Plasmodium falciparum malaria, determination of which cells and pathways are activated in the network of APCs remains elusive. We therefore investigated the effects of a controlled human malaria infection in healthy, malaria-naive volunteers on the subset composition and activation status of dendritic cells (DCs) and monocytes. While subsets of monocytes increased in frequency during bloodstage infection, DC frequencies remained largely stable. Activation markers classically associated with peptide presentation to and priming of ␣T cells, HLA-DR and CD86, were upregulated in monocytes and inflammatory CD16 myeloid DCs (mDCs) but not in the classical CD1c, BDCA2, or BDCA3 DC subsets. In addition, these activated APC subsets showed increased expression of CD1c, which is involved in glycolipid antigen presentation, and of the immune complex binding Fc␥ receptor III (CD16). Our data show that P. falciparum asexual parasites do not activate classical DC subsets but instead activate mainly monocytes and inflammatory CD16 mDCs and appear to prime alternative activation pathways via induction of CD16 and/or CD1c. Changes in expression of these surface molecules might increase antigen capture and enhance glycolipid antigen presentation in addition to the classical major histocompatibility complex class II (MHC-II) peptide presentation and thereby contribute to the initiation of T-cell responses in malaria. (This study has been registered at Clinicaltrials.gov under registration no. NCT01086917.) I nfection with the malaria parasite Plasmodium falciparum causes severe morbidity and mortality worldwide, especially in sub-Saharan Africa (1). Dendritic cells (DCs) are dedicated antigen-presenting cells (APCs) that orchestrate the immune system and are among the first immune cells to encounter the parasite after its inoculation into the skin by infected mosquitoes. Different DC subsets have been described, some being derived from or related to monocytes. Myeloid DCs (mDCs) are defined by the expression of CD1c (BDCA-1), CD141 (BDCA-3), or CD16 (Fc␥ receptor III), while the marker for plasmacytoid DCs (pDCs) is CD303 (BDCA-2) (2-4).Previous studies investigating the effect of P. falciparum exposure on DCs have shown somewhat contradictory results. In general, DC function is considered to be impaired during acute malaria, leading to immune tolerance (5, 6), based on a variety of definitions of impairment related to DC frequency (7), antigen uptake (8), viability (8), major histocompatibility complex class II (MHC-II) and costimulatory molecule expression (7, 9-11), and cytokine production (10, 11). In murine models, cross-presentation (12) and the ability to form stable interactions with T cells (13) were shown to be impaired in DCs that were exposed to P. berghei or P. chabaudi. In in vitro experiments, the effects of P. falciparum blood-stage parasites on DCs are dependent on the parasite dose used (11, 14), while differe...